Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Medium RiskFDA Device
Medical Devices

Optiflux High Flux E-beam Dialyzers Recalled for Cap Securement Issue

Agency Publication Date: October 3, 2025
Share:
Sign in to monitor this recall

Summary

Fresenius Medical Care Holdings, Inc. is recalling 172,494,732 units (14,374,561 cases) of Optiflux High Flux E-beam Dialyzers because the product caps were changed from a threaded version to a press-on version. If users do not press the caps firmly onto the dialyzer, they may not be securely attached. This recall affects various models of the Optiflux E-beam series manufactured after September 6, 2023, and aims to provide users with the correct information to ensure proper securement during use.

Risk

If the caps are not pressed firmly onto the dialyzer as required by the new design, the device may not be securely sealed. This could lead to improper functioning of the medical device or potential leakage during treatment, which may compromise patient safety.

What You Should Do

  1. The recalled products are Optiflux High Flux E-beam Dialyzers including models F160NRe, F180NRe, F200NRe, and F250NRe manufactured after September 6, 2023.
  2. Identify affected units by checking the model number and UDI-DI on the device labeling. See the Affected Products section below for the full list of affected codes.
  3. Stop using the recalled device. Contact Fresenius Medical Care Holdings, Inc. or your distributor to arrange for a return, replacement, or to receive updated usage instructions.
  4. Call the FDA Consumer Complaint hotline at 1-888-463-6332 (1-888-INFO-FDA) if you have additional questions or wish to report a concern.

Your Remedy Options

📋Other Action

Information and securement instructions

How to: Stop using the recalled device. Contact the manufacturer or your distributor to arrange return, replacement, or correction.

Affected Products

Product: Optiflux High Flux E-beam Dialyzer F160NRe (12/CS 1.5SA)
Variants: 1.5SA, EBEAM
Model / REF:
0500316E
UDI:
840861100149
Date Ranges: Manufactured after September 6, 2023

Recall #: Z-0041-2026; Quantity: 172,494,732 total units across all models.

Product: Optiflux High Flux E-beam Dialyzer F180NRe (12/CS 1.7SA)
Variants: 1.7SA, EBEAM
Model / REF:
0500318E
UDI:
840861100156
Date Ranges: Manufactured after September 6, 2023

Recall #: Z-0041-2026

Product: Optiflux High Flux E-beam Dialyzer F200NRe (12/CS 1.9SA)
Variants: 1.9SA, EBEAM
Model / REF:
0500320E
UDI:
840861100163
Date Ranges: Manufactured after September 6, 2023

Recall #: Z-0041-2026

Product: Optiflux High Flux E-beam Dialyzer F250NRe (12/CS 2.5SA)
Variants: 2.5SA, EBEAM
Model / REF:
0500325E
UDI:
840861100170
Date Ranges: Manufactured after September 6, 2023

Recall #: Z-0041-2026

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 97543
Status: Active
Manufacturer: Fresenius Medical Care Holdings, Inc.
Manufactured In: United States
Units Affected: 172,494,732 units (14,374,561 cases @ 12 units per case)
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.